Arcturus Therapeutics has appointed Andrew Sassine as Interim chief financial officer, effective August 24, 2018. Mr. Sassine has served on Arcturus’ Board of Directors since May 2018 and will continue to serve on Arcturus’ Board of Directors. The Company has initiated a search for a permanent chief financial officer. “In a short period of time since joining our Board in May, Andy has made significant contributions toward the financial stewardship of Arcturus – I am very pleased to have h...